Anticancer drugs: reduction of pulmonary toxicity.
D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008722:Methods; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000517:prevention & control
D001761:Bleomycin